menu
    • menu

    Company profile for Mina Therapeutics

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Harnessing the innate mechanism of gene activation, MiNA Therapeutics’ platform enables the development of new medicines that restore normal function to patients’ cells. We are applying our technology and clinical know-how to transform the therapy landscape in cancer and other diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Mina Therapeuticsunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    Translation & Innovation Hub 80 Wood Lane London, GB
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://minatx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/mina-therapeutics
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/MiNA_Tx

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    MiNA Therapeutics Presents New Data at EHA 2025 Congress
    MiNA Therapeutics Presents New Data at EHA 2025 Congress

    12 Jun 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250612736823/en/MiNA-Therapeutics-Presents-New-Pre-Clinical-Data-from-Sickle-Cell-Disease-Program-at-the-European-Hematology-Association-2025-Congress

    BUSINESSWIRE
    12 Jun 2025
    Share Share
    MiNA Therapeutics Appoints Bischofberger to Board and Ryan as CSO
    MiNA Therapeutics Appoints Bischofberger to Board and Ryan as CSO

    20 Mar 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250320306417/en/MiNA-Therapeutics-Appoints-Norbert-Bischofberger-Ph.D.-to-its-Board-as-Non-Executive-Director-and-Brd-Ryan-Ph.D.-MPH-as-Chief-Scientific-Officer

    BUSINESSWIRE
    20 Mar 2025
    Share Share
    MiNA Therapeutics Sickle Cell Data Presented at ASH Annual Meeting
    MiNA Therapeutics Sickle Cell Data Presented at ASH Annual Meeting

    07 Dec 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241207509163/en

    BUSINESSWIRE
    07 Dec 2024
    Share Share
    MiNA Collaboration with Nippon to Develop RNAa Therapeutics Targeting
    MiNA Collaboration with Nippon to Develop RNAa Therapeutics Targeting

    04 Apr 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240404146569/en

    BUSINESSWIRE
    04 Apr 2024
    Share Share
    NS Pharma Announces Research Alliance with MiNA Therapeutics
    NS Pharma Announces Research Alliance with MiNA Therapeutics

    04 Apr 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/ns-pharma-announces-research-alliance-with-mina-therapeutics-to-develop-therapies-for-rare-diseases-of-the-central-nervous-system-302106379.html

    PR NEWSWIRE
    04 Apr 2024
    Share Share
    Japan's NS Pharma & UK-based MiNA Therapeutics lay focus on rare diseases
    Japan's NS Pharma & UK-based MiNA Therapeutics lay focus on rare diseases

    04 Apr 2024

    // BIOSPECTRUM ASIA

    https://www.biospectrumasia.com/news/25/24044/japans-ns-pharma-uk-based-mina-therapeutics-lay-focus-on-rare-diseases-of-central-nervous-system.html

    BIOSPECTRUM ASIA
    04 Apr 2024
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search